PREVENTICUS GMBH

Their core work

Preventicus is a German digital health SME based in Jena that develops smartphone-based cardiac diagnostic technology, best known for photoplethysmography (PPG) and ECG analytics that detect atrial fibrillation before it causes a stroke. Their software turns a standard smartphone camera into a medically certified rhythm screening tool, processing pulse waveforms with signal processing and machine learning to flag arrhythmias. They sell to health insurers, hospitals and clinical research projects as a scalable alternative to Holter monitors. In EU projects they bring the patient-facing digital diagnostic layer — the mobile measurement, cloud pipeline and AI-based classification of cardiac signals.

What they specialise in

How they've shifted over time

In the first H2020 engagement (RedStroke, 2018–2021) Preventicus acted as a commercial SME coordinator, focused on bringing a market-ready AF screening product to scale under the SME Instrument. In the second phase (MAESTRIA, 2021–2026) they shifted into a research-intensive RIA consortium, contributing their diagnostic pipeline to a broader effort combining machine learning, cardiac imaging and data integration for personalised stroke prevention. The trajectory moves from productising a narrow screening tool toward embedding their technology into AI-driven, multimodal cardiovascular medicine.

They are moving from a single-product AF screening SME toward a data and AI partner inside larger clinical research consortia on atrial cardiomyopathy and personalised stroke prevention.

How they like to work

Preventicus has played both lead and partner roles: they coordinated the SME-instrument project RedStroke on their own technology, and joined the large MAESTRIA RIA consortium as one specialist partner. This suggests a company confident enough to run its own innovation project but also willing to plug into bigger clinical-academic networks when the science requires it. For collaborators, they are a practical industry contact who can both own a work package and contribute a deployable digital endpoint.

Across the two projects they have worked with around 20 distinct partners in 8 countries, anchored in Germany but reaching into broader European cardiovascular research networks through the MAESTRIA consortium.

What sets them apart

Unlike most cardiology research partners, Preventicus is a commercial digital-health SME with a CE-marked, smartphone-delivered AF detection product already in market use. That makes them unusual in consortia: they provide a real patient-facing tool and data pipeline, not just a prototype. For partners needing scalable remote cardiac screening or an industry endpoint for clinical validation, they offer something few German medtech SMEs can match.

Highlights from their portfolio

• RedStroke
  Their own coordinated SME-instrument project with €2.49M — essentially a dedicated scale-up vehicle for their AF screening technology.
• MAESTRIA
  Places them inside a flagship Horizon Health RIA on atrial cardiomyopathy and AI-based stroke prevention, extending their reach from product into clinical AI research.